| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.CYTOGFR.2004.03.004 |
| P698 | PubMed publication ID | 15207815 |
| P2093 | author name string | Elaine W Raines | |
| P2860 | cites work | RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class | Q34308033 |
| Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall | Q35967045 | ||
| P433 | issue | 4 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 237-254 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
| P1476 | title | PDGF and cardiovascular disease | |
| P478 | volume | 15 |
| Q89858408 | 'HIGH RISK' CLINICAL AND INFLAMMATORY CLUSTERS IN COPD OF CHINESE DESCENT |
| Q43185046 | A CXCL5- and bFGF-dependent effect of PDGF-B-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells |
| Q64883475 | A Human Pluripotent Stem Cell-Based Screen for Smooth Muscle Cell Differentiation and Maturation Identifies Inhibitors of Intimal Hyperplasia. |
| Q38541273 | A Novel Approach against Vascular Intimal Hyperplasia Through the Suppression of Girdin |
| Q37410202 | A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents |
| Q42726669 | A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat. |
| Q35799977 | A naturally occurring carotenoid, lutein, reduces PDGF and H₂O₂ signaling and compromised migration in cultured vascular smooth muscle cells |
| Q37707729 | A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model |
| Q37715756 | Activation transcription factor-4 and the acute vascular response to injury. |
| Q34002877 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells |
| Q43661962 | Adventitial fibroblasts from apoE(-/-) mice exhibit the characteristics of transdifferentiation into myofibroblasts |
| Q42719726 | Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia |
| Q44895650 | Anthocyanidins, novel FAK inhibitors, attenuate PDGF-BB-induced aortic smooth muscle cell migration and neointima formation |
| Q35657503 | Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells |
| Q55059475 | Antiproliferative Activity of Hinokitiol, a Tropolone Derivative, Is Mediated via the Inductions of p-JNK and p-PLCγ1 Signaling in PDGF-BB-Stimulated Vascular Smooth Muscle Cells. |
| Q92021254 | Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysis |
| Q30416293 | Atherosclerosis susceptibility Loci identified in an extremely atherosclerosis-resistant mouse strain |
| Q42859208 | Bisdemethoxycurcumin inhibits PDGF-induced vascular smooth muscle cell motility and proliferation |
| Q36114066 | Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. |
| Q37235264 | Blockade of Urotensin II Receptor Prevents Vascular Dysfunction |
| Q36109679 | Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells |
| Q30419933 | Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation |
| Q58118024 | Bone marrow-derived mesenchymal stem cells inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia after arterial injury in rats |
| Q53345221 | Camptothecin inhibits platelet-derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells through inhibition of PI3K/Akt signaling pathway. |
| Q33559670 | Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload |
| Q47812869 | Cardiovascular and Hemostatic Disorders: Role of STIM and Orai Proteins in Vascular Disorders |
| Q35132810 | Cell-cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness |
| Q38506920 | Cells and stimuli in small-caliber blood vessel tissue engineering |
| Q41717951 | Chebulinic acid inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression |
| Q45982870 | Chitosan nanoparticle carrying small interfering RNA to platelet-derived growth factor B mRNA inhibits proliferation of smooth muscle cells in rabbit injured arteries. |
| Q37862219 | Co-infection ratios versus inflammation, growth factors and progression of early atheromas |
| Q50452526 | Computational model of collagen turnover in carotid arteries during hypertension. |
| Q30666915 | Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function |
| Q91766454 | Copper transporter ATP7A interacts with IQGAP1, a Rac1 binding scaffolding protein: role in PDGF-induced VSMC migration and vascular remodeling |
| Q99609326 | Correlation between the Serum Platelet-Derived Growth Factor, Angiopoietin-1, and Severity of Coronary Heart Disease |
| Q90292298 | Cortistatin, a novel cardiovascular protective peptide |
| Q41817139 | Cytochrome P450 1B1 Contributes to the Development of Angiotensin II-Induced Aortic Aneurysm in Male Apoe(-/-) Mice |
| Q58126981 | Cytochrome P450 1B1 Is Critical for Neointimal Growth in Wire-Injured Carotid Artery of Male Mice |
| Q42713451 | Dehydroglyasperin C, a component of liquorice, attenuates proliferation and migration induced by platelet-derived growth factor in human arterial smooth muscle cells |
| Q40466167 | Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity. |
| Q49893120 | Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells |
| Q28569329 | Differential and combined effects of cardiotrophin-1 and TGF-beta1 on cardiac myofibroblast proliferation and contraction |
| Q34542793 | Differential regulation of human aortic smooth muscle cell proliferation by monocyte-derived macrophages from diabetic patients |
| Q36041722 | Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury |
| Q24306656 | Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo |
| Q37633078 | Drug- and Gene-eluting Stents for Preventing Coronary Restenosis |
| Q34137840 | Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production |
| Q34060911 | Effect of substrate stiffness and PDGF on the behavior of vascular smooth muscle cells: implications for atherosclerosis |
| Q88342956 | Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts |
| Q36693045 | Effects of external wrapping and increased blood flow on atrophy of the baboon iliac artery |
| Q37388899 | Ephrin-B2 controls PDGFRβ internalization and signaling |
| Q33840443 | Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration |
| Q46192896 | Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells |
| Q45350706 | Eupatolide inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through ROS-dependent heme oxygenase-1 induction |
| Q36080941 | Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation. |
| Q42068247 | Folic acid inhibits dedifferentiation of PDGF-BB-induced vascular smooth muscle cells by suppressing mTOR/P70S6K signaling |
| Q36089708 | Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemia |
| Q54576212 | Glyceollins inhibit platelet-derived growth factor-mediated human arterial smooth muscle cell proliferation and migration. |
| Q80216002 | Gremlin promotes vascular smooth muscle cell proliferation and migration |
| Q28570860 | Histone deacetylase-1 is enriched at the platelet-derived growth factor-D promoter in response to interleukin-1beta and forms a cytokine-inducible gene-silencing complex with NF-kappab p65 and interferon regulatory factor-1 |
| Q35531909 | History of discovery: platelet-derived growth factor |
| Q84739859 | Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells |
| Q28568374 | IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury |
| Q39966947 | Identification and expression analysis of an N-terminally truncated isoform of human PDGF-C. |
| Q37245068 | Identification of platelet-derived growth factor D in human chronic allograft nephropathy |
| Q37302839 | Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells. |
| Q53121884 | Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells. |
| Q37954724 | Imatinib mesylate for the treatment of pulmonary arterial hypertension |
| Q54667187 | Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis. |
| Q37397465 | Immunolocalization of platelet-derived growth factor receptor-β (PDGFR-β) and pericytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). |
| Q34004655 | In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. |
| Q28581716 | Increased myosin light chain kinase expression in hypertension: Regulation by serum response factor via an insertion mutation in the promoter |
| Q39048502 | Inflammation and vascular smooth muscle cell dedifferentiation following carotid artery ligation |
| Q37459881 | Injury-induced platelet-derived growth factor receptor-alpha expression mediated by interleukin-1beta (IL-1beta) release and cooperative transactivation by NF-kappaB and ATF-4: IL-1beta facilitates HDAC-1/2 dissociation from promoter. |
| Q34349858 | Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging |
| Q40980359 | Interleukin-32α Inhibits Endothelial Inflammation, Vascular Smooth Muscle Cell Activation, and Atherosclerosis by Upregulating Timp3 and Reck through suppressing microRNA-205 Biogenesis |
| Q28551230 | Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis |
| Q47756210 | Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis |
| Q34897476 | Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension? |
| Q24321728 | Kruppel-like factor 15 is critical for vascular inflammation |
| Q36147361 | Krüppel-like factor 4 is induced by rapamycin and mediates the anti-proliferative effect of rapamycin in rat carotid arteries after balloon injury |
| Q43125682 | Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF. |
| Q36791246 | Magnobovatol inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression |
| Q45077001 | Mathematical modeling of collagen turnover in biological tissue |
| Q34946905 | Mechanical stretch increases MMP-2 production in vascular smooth muscle cells via activation of PDGFR-β/Akt signaling pathway |
| Q36990691 | Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors |
| Q47104906 | MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1. |
| Q42263688 | MiR-339 inhibits proliferation of pulmonary artery smooth muscle cell by targeting FGF signaling |
| Q92983364 | MiR-638 Repressed Vascular Smooth Muscle Cell Glycolysis by Targeting LDHA |
| Q60922850 | MicroRNA-320 targeting neuropilin 1 inhibits proliferation and migration of vascular smooth muscle cells and neointimal formation |
| Q36943405 | MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1 |
| Q64055458 | MicroRNA-92a promotes vascular smooth muscle cell proliferation and migration through the ROCK/MLCK signalling pathway |
| Q36156872 | Multi-omics analysis reveals regulators of the response to PDGF-BB treatment in pulmonary artery smooth muscle cells. |
| Q35683209 | NADPH oxidase 4 mediates monocyte priming and accelerated chemotaxis induced by metabolic stress. |
| Q24647879 | Neuraminidase-1, a subunit of the cell surface elastin receptor, desialylates and functionally inactivates adjacent receptors interacting with the mitogenic growth factors PDGF-BB and IGF-2 |
| Q42243380 | Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells |
| Q40311477 | New therapeutic possibilities for vein graft disease in the post-edifoligide era. |
| Q42538041 | Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway |
| Q57063657 | Nicotinic acetylcholine receptor α7 inhibits platelet-derived growth factor-induced migration of vascular smooth muscle cells by activating mitochondrial deacetylase SIRT3 |
| Q28580309 | Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury |
| Q40089541 | Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells |
| Q42426487 | Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor. |
| Q38696169 | Optimizing endothelial cell functionalization for cell therapy of vascular proliferative disease using a direct contact co-culture system. |
| Q36698766 | Orai channel-mediated Ca2+ signals in vascular and airway smooth muscle |
| Q43095674 | Osteopontin, a missing link in PDGF-induced smooth muscle cell migration |
| Q35578774 | Ovarian wedge resection restores fertility in estrogen receptor beta knockout (ERbeta-/-) mice |
| Q24813774 | Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression |
| Q38185014 | PDGF and the progression of renal disease. |
| Q36120513 | PDGF-D gene polymorphism is associated with increased cardiovascular mortality in elderly men. |
| Q30425676 | PDGF-dependent regulation of regulator of G protein signaling-5 expression and vascular smooth muscle cell functionality |
| Q50021212 | PDGF-induced migration of synthetic vascular smooth muscle cells through c-Src-activated L-type Ca2+ channels with full-length CaV1.2 C-terminus |
| Q35680187 | PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. |
| Q34191687 | PDGFRβ signaling regulates mural cell plasticity and inhibits fat development. |
| Q35865871 | PDGFRβ signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis |
| Q37689190 | PPARgamma as a potential therapeutic target in pulmonary hypertension |
| Q38329304 | Patterns of gene expression differentially regulated by platelet-derived growth factor and hypertrophic stimuli in vascular smooth muscle cells: markers for phenotypic modulation and response to injury |
| Q48313522 | Phenotypic switching prevention and proliferation/migration inhibition of vascular smooth muscle cells by the ruthenium nitrosyl complex trans-[Ru(NO)Cl(cyclam](PF6 )2. |
| Q26829051 | Phospholipase C signaling and calcium influx |
| Q36195042 | Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia |
| Q51927617 | Platelet-derived growth factor is involved in the differentiation of second heart field-derived cardiac structures in chicken embryos. |
| Q37761374 | Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature |
| Q44923453 | Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters |
| Q37728747 | Platonin inhibited PDGF-BB-induced proliferation of rat vascular smooth muscle cells via JNK1/2-dependent signaling |
| Q37218194 | Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. |
| Q42979847 | Protein kinase Cδ mediates MCP-1 mRNA stabilization in vascular smooth muscle cells |
| Q42946155 | Protein tyrosine phosphatase PTPεM negatively regulates PDGF β-receptor signaling induced by high glucose and PDGF in vascular smooth muscle cells |
| Q37510851 | Redox control of the cell cycle in health and disease |
| Q37898749 | Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing? |
| Q34460553 | Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury |
| Q47904887 | Refinement of tourniquet-induced peripheral ischemia/reperfusion injury in rats: comparison of 2 h vs 24 h reperfusion |
| Q34606581 | Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. |
| Q37265804 | Role of PDGF in fibrotic diseases and systemic sclerosis |
| Q37452120 | Role of PDGFs/PDGFRs signaling pathway in myocardial fibrosis of DOCA/salt hypertensive rats |
| Q24329111 | Role of coronin 1B in PDGF-induced migration of vascular smooth muscle cells |
| Q29615222 | Role of platelet-derived growth factors in physiology and medicine |
| Q35152938 | Scoparone interferes with STAT3-induced proliferation of vascular smooth muscle cells. |
| Q90720241 | Semaphorin-3A protects against neointimal hyperplasia after vascular injury |
| Q50089075 | Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation |
| Q33781870 | Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X |
| Q45855018 | Serum starvation and growth factor receptor expression in vascular smooth muscle cells |
| Q53092489 | Shh mediates PDGF-induced contractile-to-synthetic phenotypic modulation in vascular smooth muscle cells through regulation of KLF4. |
| Q64894416 | Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts. |
| Q47100278 | Small molecule-mediated induction of miR-9 suppressed vascular smooth muscle cell proliferation and neointima formation after balloon injury. |
| Q37021191 | Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). |
| Q42120287 | Smooth muscle homeostasis in human atherosclerotic plaques through interleukin 15 signalling |
| Q54319356 | Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration. |
| Q30436555 | Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle |
| Q40831873 | Store-independent Orai1/3 channels activated by intracrine leukotriene C4: role in neointimal hyperplasia |
| Q37378697 | Substrate Stiffness Regulates PDGF-Induced Circular Dorsal Ruffle Formation Through MLCK. |
| Q33720170 | Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling |
| Q36827659 | Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease |
| Q39581315 | TGFβ1 suppresses vascular smooth muscle cell motility by expression of N-cadherin |
| Q90084151 | TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation |
| Q38038222 | Targeting PDGF pathway in pulmonary arterial hypertension |
| Q34352802 | Targeting the PDGF signaling pathway in the treatment of non-malignant diseases |
| Q38567570 | Targeting the platelet-derived growth factor signalling in cardiovascular disease |
| Q39500221 | Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. |
| Q33988364 | Tetrahydrobiopterin Inhibits PDGF-stimulated Migration and Proliferation in Rat Aortic Smooth Muscle Cells via the Nitric Oxide Synthase-independent Pathway |
| Q38704867 | The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor β Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Target |
| Q24677863 | The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation |
| Q60313269 | The Potential of Fluocinolone Acetonide to Mitigate Inflammation and Lipid Accumulation in 2D and 3D Foam Cell Cultures |
| Q42694416 | The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis |
| Q35221833 | The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice |
| Q58071384 | The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways |
| Q37121807 | The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway |
| Q24606673 | The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease |
| Q35221544 | The matricellular protein Cyr61 is a key mediator of platelet-derived growth factor-induced cell migration |
| Q36369252 | The orphan nuclear receptor Nur77 inhibits low shear stress-induced carotid artery remodeling in mice |
| Q37766123 | The paracrine effect: pivotal mechanism in cell-based cardiac repair |
| Q36582676 | Therapeutic effects of water soluble danshen extracts on atherosclerosis. |
| Q35535644 | Tissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cells |
| Q41884604 | Transcription factor cAMP response element modulator (Crem) restrains Pdgf-dependent proliferation of vascular smooth muscle cells in mice |
| Q37119705 | Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells |
| Q35053942 | Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation |
| Q36130517 | Transplantation of EPCs overexpressing PDGFR-β promotes vascular repair in the early phase after vascular injury |
| Q28565782 | Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration |
| Q90694896 | Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis |
| Q43216546 | Vasculoprotective effect of cilostazol in aldosterone-induced hypertensive rats |
| Q59126562 | Versican is differentially regulated in the adventitial and medial layers of human vein grafts |
| Q36335468 | Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration |
| Q36225148 | Viscolin Inhibits In Vitro Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia In Vivo |
| Q99631052 | Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects |
| Q34550096 | Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation |
| Q34558029 | Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo |
| Q58552367 | miR-365b-3p inhibits the cell proliferation and migration of human coronary artery smooth muscle cells by directly targeting ADAMTS1 in coronary atherosclerosis |
| Q42147279 | miR-379 Inhibits Cell Proliferation, Invasion, and Migration of Vascular Smooth Muscle Cells by Targeting Insulin-Like Factor-1. |
| Q36804819 | n-3 PUFA in CVD: influence of cytokine polymorphism |
Search more.